BioAge

BioAge is a clinical-stage biotechnology company focused on metabolic diseases, especially obesity, by targeting the biology of human aging. It develops therapeutic candidates such as APJ agonists and NLRP3 inhibitors, and has reported collaboration revenue while its product candidates remain in clinical development.

Relationship details are part of the Pro plan.